KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolent Health (EVH) Operating Expenses (2016 - 2025)

Evolent Health (EVH) has 11 years of Operating Expenses data on record, last reported at $79.0 million in Q4 2025.

  • For Q4 2025, Operating Expenses fell 88.13% year-over-year to $79.0 million; the TTM value through Dec 2025 reached $1.5 billion, down 42.65%, while the annual FY2025 figure was $330.2 million, 50.36% down from the prior year.
  • Operating Expenses reached $79.0 million in Q4 2025 per EVH's latest filing, down from $478.6 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $665.1 million in Q4 2024 and bottomed at $79.0 million in Q4 2025.
  • Average Operating Expenses over 5 years is $420.9 million, with a median of $441.8 million recorded in 2023.
  • Peak YoY movement for Operating Expenses: surged 55.74% in 2023, then tumbled 88.13% in 2025.
  • A 5-year view of Operating Expenses shows it stood at $260.6 million in 2021, then surged by 47.49% to $384.3 million in 2022, then soared by 50.24% to $577.4 million in 2023, then grew by 15.19% to $665.1 million in 2024, then crashed by 88.13% to $79.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Expenses were $79.0 million in Q4 2025, $478.6 million in Q3 2025, and $445.5 million in Q2 2025.